INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• 5 Projections For 2026: Navigating The New Normal In Clinical Trials

  In 2026, clinical trial success depends on moving from AI hype to proven utility. Unified data and seamless site experiences are no longer optional; they are the keys to trial resilience.

• Who Is Responsible When AI Helps Write The Consent Form?

  AI is reshaping consent materials, but accuracy, oversight, and transparency remain essential. As guidance evolves, organizations must balance innovation with accountability to protect participants.

• Selecting And Expanding Your EDC System: A Testimonial From Everest Clinical Research

  Everest Clinical Research shares what lead them to strengthen their partnership with Medidata, and expand past the use of Medidata's EDC products too other helpful solutions.

• The Real Payoff Of Reusable IRT/RTSM System Design

  By utilizing consistent, repeatable system builds, sponsors gain significant advantages during protocol amendments and operational changes.

• Diversity In Clinical Trials: LGBTQIA+ Community Needs Not Just Allies, But Crusaders

  9/9/2024

  In an ACRP webinar on LGBTQIA+ diversity in clinical trials, industry panelists came together to discuss FDA action plans, SOGI data, advocacy efforts, challenges of transgender patients, and more.

• Streamlining Translations For Global Studies

  3/27/2025

  Ensure seamless, accurate global study translations and efficient localization with IQVIA eCOA, leveraging our proven vendor relationships and streamlined process to keep your study on track.

• Capture Was Step One. Execution Is Step Two.

  5/21/2026

  Electronic data capture transformed clinical trials, but advancing a study depends on decision workflows that interpret data, coordinate teams, and determine meaningful next actions.

• Interpreting Early Inflammation Signals: What Early Human Data Tells Us

  7/10/2026

  Early inflammatory signals can mislead without context. Benchmarked human challenge models reveal true biological activity, guiding decisions on mechanism, dosing, and clinical development.

• Addressing Trial Design Hurdles Across Alzheimer's Disease Stages

  12/10/2025

  Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.